News

The AHA Dec. 3 released its 2026 Health Care Workforce Scan (https://www.aha.org/aha-workforce-scan) — an annual snapshot of America’s hospital and health system employment based on reports, studies and other data sources from leading organizations and researchers.

The Centers for Medicare & Medicaid Services has updated its GitHub repository with new resources to help hospitals comply with changes to hospital price transparency requirements finalized in the Medicare hospital outpatient prospective payment system final rule for calendar year 2026.

The FBI has public resources available to help prevent exploitation by cybercriminals, who use artificial intelligence for deception.

Thomas Lee, M.D., chief medical officer of Press Ganey and editor-in-chief of NEJM Catalyst, explores why social capital is becoming the most critical asset in leadership development, how it can drive organizational performance and why physicians must act intentionally to enable high-reliability teams.

The Centers for Medicare & Medicaid Services Dec. 2 repealed the minimum staffing requirements for nursing homes that participate in Medicare and Medicaid that the agency adopted in 2024.

The Trump administration announced a trade agreement with the U.K. Dec. 1 on pharmaceuticals that exempts U.K. drug products from Section 232 tariffs. In exchange, the U.K. will increase the net price it pays for new medicines by 25%.  

President Trump Dec. 1 signed the AHA-supported SUPPORT Act (H.R. 2483) into law. The legislation reauthorizes key prevention, treatment and recovery programs for patients with substance use disorder. It also includes programs to support the behavioral health workforce. 

A coalition of organizations, including the AHA, urged the Centers for Medicare & Medicaid Services to ensure accountable care organizations and Merit-based Incentive Payment System-eligible clinicians are held harmless from increased billing for skin substitutes.

The House Dec. 1 passed the Hospital Inpatient Services Modernization Act (H.R. 4313), legislation extending certain Medicare waivers authorizing the hospital-at-home care program for five years.

The AHA, the Maine Hospital Association and four safety-net health systems from across the country Dec. 1 filed a lawsuit in the U.S. District Court for the District of Maine to challenge the 340B Rebate Model Pilot Program.

The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of artificial intelligence-enabled medical devices.

The Centers for Medicare & Medicaid Services Innovation Center will launch a new, outcome-aligned payment model

The Centers for Medicare & Medicaid Services announced Dec. 1 that it intends to expand the Inpatient Rehabilitation Facility Review Choice Demonstration to include IRFs in Texas and California.

The Food and Drug Administration has identified a

Eilidh Pederson, CEO at Western Wisconsin Health, shares lessons from her unique birthing experience — in which she delivered her own baby — and outlines how rural hospitals can continue to provide

The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations under the Inflation Reduction Act’s Medicare Drug Price Negotiation Program.

The Assistant Secretary for Technology Policy/Office of the National Coordinator for Health IT announced Nov. 24 that it will exercise temporary enforcement discretion for health IT developers regarding certification criteria compliance dates and attestations of condition and maintenance for certification to account for the impact of the lapse in government appropriations which rendered the ASTP/ONC website unavailable, including access to attestation submission portals, testing tools and other resources.

The Centers for Medicare & Medicaid Services Nov. 25 issued a proposed rule for policies governing the Medicare Advantage and Part D programs for 2027.

The Trump administration issued an executive order (https://www.whitehouse.gov/presidential-actions/2025/11/launching-the-genesis-mission/) Nov. 24 launching the Genesis Mission, an artificial intelligence initiative focusing on scientific research.

The Food and Drug Administration has identified a Class I recall of Max Mobility/Permobil SpeedControl Dials used with the SmartDrive MX2+ Power Assist Device for wheelchairs after identifying a design issue that can lead to unexpected behavior of the SmartDrive motor.